The Latest Headlines at Daily Political
Abbott Laboratories (ABT) to Release Earnings on Wednesday
Abbott Laboratories (NYSE:ABT – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Wednesday, April 17th. Analysts expect Abbott Laboratories to post earnings of $0.95 per share for... More of this article »
Qualys (NASDAQ:QLYS) Lifted to “Buy” at StockNews.com
StockNews.com upgraded shares of Qualys (NASDAQ:QLYS – Free Report) from a hold rating to a buy rating in a research report released on Saturday. Several other analysts also recently commented on QLYS. Truist Financial increased... More of this article »
Papa John’s International (NASDAQ:PZZA) Coverage Initiated by Analysts at Stephens
Stephens began coverage on shares of Papa John’s International (NASDAQ:PZZA – Free Report) in a research note issued to investors on Friday, Marketbeat.com reports. The brokerage issued an overweight rating and a $75.00... More of this article »
Cantor Fitzgerald Reaffirms Overweight Rating for Polestar Automotive Holding UK (NASDAQ:PSNY)
Cantor Fitzgerald reaffirmed their overweight rating on shares of Polestar Automotive Holding UK (NASDAQ:PSNY – Free Report) in a research note issued to investors on Friday, Benzinga reports. Cantor Fitzgerald currently has... More of this article »
Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s... More of this article »
StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX)
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report issued on Friday. The brokerage issued a sell rating on the stock. OncoCyte Price Performance Shares of NASDAQ OCX opened at $2.53 on Friday.... More of this article »
Needham & Company LLC Reiterates Buy Rating for Napco Security Technologies (NASDAQ:NSSC)
Needham & Company LLC restated their buy rating on shares of Napco Security Technologies (NASDAQ:NSSC – Free Report) in a report released on Friday morning, Benzinga reports. Needham & Company LLC currently has a $46.00... More of this article »
Stifel Nicolaus Raises Canadian National Railway (NYSE:CNI) Price Target to $134.00
Canadian National Railway (NYSE:CNI – Free Report) (TSE:CNR) had its price objective raised by Stifel Nicolaus from $121.00 to $134.00 in a research note issued to investors on Friday, Benzinga reports. They currently have a... More of this article »
Viavi Solutions (NASDAQ:VIAV) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Viavi Solutions (NASDAQ:VIAV – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday morning. VIAV has been the topic of several other research reports.... More of this article »
Vera Bradley (NASDAQ:VRA) Lifted to “Strong-Buy” at StockNews.com
StockNews.com upgraded shares of Vera Bradley (NASDAQ:VRA – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday. Vera Bradley Trading Up 0.3 % Shares of VRA opened at $6.37... More of this article »
Wingstop (NASDAQ:WING) Price Target Increased to $315.00 by Analysts at Morgan Stanley
Wingstop (NASDAQ:WING – Free Report) had its price objective lifted by Morgan Stanley from $280.00 to $315.00 in a report published on Friday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the... More of this article »
Target Hospitality’s (TH) “Hold” Rating Reiterated at Stifel Nicolaus
Stifel Nicolaus restated their hold rating on shares of Target Hospitality (NASDAQ:TH – Free Report) in a research note released on Friday, Marketbeat Ratings reports. They currently have a $12.00 price target on the stock,... More of this article »
Sorrento Therapeutics (NASDAQ:SRNE) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report released on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics... More of this article »